Li Zhou is an accomplished scientist with extensive experience in antibody discovery, molecular biology, and therapeutic development. Currently serving as a Staff Scientist at Alector since November 2022, Li Zhou previously held positions as a Senior Scientist at Zai Lab US LLC, where an in-house NGS-based antibody discovery platform was established, and at Immune-Onc Therapeutics, where CRISPR CAR-T systems were developed. Earlier roles include contributions at Atreca, Inc., focusing on yeast surface display techniques, and at Sorrento Therapeutics, Inc., where innovative phage-panning systems for cancer targets were designed. Li Zhou's research origins are rooted in molecular biochemistry, with a Ph.D. from The University of Texas at Austin and initial training as an undergraduate research assistant at Tsinghua University.
This person is not in the org chart
This person is not in any offices